Navigenics promises a peek at your genome — next year

Navigenics, which plans to offer individuals a personalized genetic analysis so they can better manage their health, “launched” its service — sort of — and announced that it has raised more than $25 million.

As we point out at VentureBeat Life Sciences, however, the company’s launch is really just a promise to begin its service early next year, at a price of $2,500 per person. Navigenics also lined up Mohr Davidow Ventures — an early backer of potential competitor 23andMe — as a new investor, and we’re also told that Google, which has both personal and financial ties to 23andMe, has quietly invested in Navigenics as well.